Kidney tubular toxicity of maintenance pemetrexed therapy.

TitleKidney tubular toxicity of maintenance pemetrexed therapy.
Publication TypeJournal Article
Year of Publication2011
AuthorsGlezerman IG, M Pietanza C, Miller V, Seshan SV
JournalAm J Kidney Dis
Volume58
Issue5
Pagination817-20
Date Published2011 Nov
ISSN1523-6838
KeywordsAged, Antimetabolites, Antineoplastic, Female, Glutamates, Guanine, Humans, Kidney Diseases, Kidney Tubules, Male, Middle Aged, Pemetrexed
Abstract

Pemetrexed is an antifolate agent approved for the treatment of advanced lung cancer. Major side effects include myelosuppression and neutropenia. Three patients developed kidney disease while being treated with maintenance pemetrexed. Kidney biopsy specimens showed tubulointerstitial injury with tubular simplification, shrinkage, loss of brush border, and tubular atrophy in a more advanced case. Kidney function remained impaired, but stable, after discontinuation of pemetrexed therapy in all cases.

DOI10.1053/j.ajkd.2011.04.030
Alternate JournalAm J Kidney Dis
PubMed ID21849225
Related Faculty: 
Surya V. Seshan, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700